Panel Discussion: Rationalizing the CQAs of Polymer Delivery Vehicles to Promote Batch to Batch Consistency, Reducing Regulatory Scrutiny
Time: 12:15 pm
day: Conference Day Two
Details:
- Distinguishing the current critical quality attributes industry and academia are utilising to assess the potency of the drug product
- Determining how important the size of the polymeric molecule could prove to be in the delivery of the API
- Comparing drug products to understand CQAs which remain a constant for regulators and areas which creates variability
